-
Sector Analysis
Anal Cancer (AC) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Anal Cancer Marketed and Pipeline Drugs Report Overview Anal cancer develops in the cells and tissue of the skin lining on either the inside or outside of the anus. The development of anal cancer is directly linked to a complex inflammatory process secondary to infections such as (HPV) types 16 and 18. The progression of this inflammatory process heralds the development of anal intraepithelial neoplasia (AIN), or squamous cell carcinoma (SCC) in situ (Bowen disease), which is a pre-malignant condition....
-
Product Insights
Ace In The Hole Mine
The Ace In The Hole Mine is a coal mine in United States. It is currently in operation. Empower your strategies with our Ace In The Hole Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and...
-
Product Insights
Bakun AC
Bakun AC is a Hydro project located in Ilocos, Philippines. The project is owned by Aboitiz Equity Ventures Inc; JERA Co Inc and others; PCD Nominee Corp and was developed by Luzon Hydro Corporation. The project came online in 2000. Empower your strategies with our Bakun AC report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase,...
-
Product Insights
Aces Branch Mine #9
The Aces Branch Mine #9 is a coal mine in United States. It is currently in operation. Empower your strategies with our Aces Branch Mine #9 report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tricaprilin in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tricaprilin in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tricaprilin in Parkinson's Disease Drug Details: Tricaprilin (AC-1204) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tricaprilin in Infantile Spasm (West Syndrome)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tricaprilin in Infantile Spasm (West Syndrome) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tricaprilin in Infantile Spasm (West Syndrome) Drug Details: Tricaprilin (AC-1204)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Amlodipine + Bisoprolol + Indapamide + Perindopril) in Idiopathic (Essential) Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Amlodipine + Bisoprolol + Indapamide + Perindopril) in Idiopathic (Essential) Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Amlodipine + Bisoprolol + Indapamide...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Actimab-A in Refractory Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Actimab-A in Refractory Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Actimab-A in Refractory Acute Myeloid Leukemia Drug Details: Actimab-A (HuM195-Ac-225)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Actimab-A in Relapsed Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Actimab-A in Relapsed Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Actimab-A in Relapsed Acute Myeloid Leukemia Drug Details: Actimab-A (HuM195-Ac-225)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Actimab-A in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Actimab-A in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Actimab-A in Acute Myelocytic Leukemia (AML, Acute...